Key Highlights
- Appointment of Amy Ables, Ph.D. as Chief Strategy Officer at Catalyst OrthoScience Inc., effective immediately.
- Ables brings nearly 20 years of experience in medical device industry, specializing in upper extremity orthopedics.
- Previous roles include leadership positions at Tornier, Wright Medical, ATEC Spine, and Cutera, with a focus on customer engagement, sales, and strategy development.
Source: Business Wire
Notable Quotes
- “The board and I are excited to have an executive with Dr. Ables’ experience and leadership join our team at Catalyst OrthoScience,” – Carl O’Connell, CEO and President at Catalyst OrthoScience
- “I am grateful and excited to embrace this opportunity with the Catalyst team… I look forward to contributing with vigor and vision, steering our efforts toward growth and excellence,” – Amy Ables, Ph.D., Chief Strategy Officer at Catalyst OrthoScience
SoH's Take
The appointment of Dr. Amy Ables as the Chief Strategy Officer at Catalyst OrthoScience Inc. is a strategic move that underscores the company’s commitment to innovation and leadership in the upper extremity orthopedics market. With Dr. Ables’ extensive background and proven track record in the medical device industry, particularly in upper extremity orthopedics, Catalyst OrthoScience is poised for significant advancements in its operational capabilities and market impact. Her leadership and expertise will be invaluable in driving the company’s growth and scaling its operations, aligning with Catalyst’s vision of less invasive, patient-centric shoulder replacement solutions. This marks an exciting phase for Catalyst OrthoScience as it continues to make strides in revolutionizing shoulder replacement surgery with its unique, patient-focused approach.
